Trump Accelerates Psychedelic Research With $50 Million Ibogaine Commitment

On Saturday, President Donald Trump signed an executive order directing the U.S. Food and Drug Administration to move faster on reviews tied to psychedelic-based research and treatment, including ibogaine that veteran advocates say may help post-traumatic stress disorder. Importance Rank: 1 read more

Go to News Site